MRK
Merck & Company IncNYSE
Healthcare • Drug Manufacturers - General
Factor tilt: Mega-Cap Blend
$146.73-0.14%
Close Nov 6, 2026
- Market cap
- $362.4B
- 1 month
- +3.1%
- 3 months
- +12.1%
- 1 year
- +73.9%
- 52-week range
- $86.28$156.45
- Dividend, last 12 mo
- $3.40 · 2.32% yield
- Last ex-date
- Sep 15, 2026 · $0.85
- Dividend growth
- 15+ years in a row
- Short interest
- 1.1% of float26.8M shares · settled Oct 15, 2026 · -5.1% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $67.3B
- Net income
- $2.45B
- Free cash flow
- $14.75B
- Book value
- $44.89B
- Total debt
- $53.78B
- P/E
- 147.7×
- Price / sales
- 5.4×
- Price / book
- 8.1×
- FCF yield
- +4.1%
- Net margin
- +3.6%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
Read more
The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
- Website
- merck.com
- Headquarters
- Rahway, NJ, United States
- Employees
- 73,000
- Listed
- Jan 13, 1978
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 7, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 4, 2026 | $18.1B | +5.2% | 81.4% | $7.3B | $5.1B |
| Jun 2026filed Aug 7, 2026 | $16.6B | +5.1% | 73.5% | -$683.0M | -$1.3B |
| Mar 2026filed May 4, 2026 | $16.3B | +4.3% | 81.9% | -$1.9B | -$4.2B |
| Dec 2025filed Feb 24, 2026 | $16.3B | +4.5% | 70.5% | $6.2B | $3.0B |
| Sep 2025filed Nov 5, 2025 | $17.2B | +3.2% | 75.6% | $7.5B | $5.8B |
| Jun 2025filed Aug 5, 2025 | $15.8B | -1.9% | 75.7% | $6.4B | $4.4B |
| Mar 2025filed May 2, 2025 | $15.6B | -1.0% | 75.1% | $6.7B | $5.1B |
| Dec 2024filed Feb 25, 2025 | $15.6B | +6.8% | 75.5% | $4.3B | $3.7B |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 24, 2026 | $64.9B | +1.2% | 72.0% | $23.5B | $18.3B |
| Dec 2024filed Feb 25, 2025 | $64.2B | +6.7% | 76.3% | $20.2B | $17.1B |
| Dec 2023filed Feb 26, 2024 | $60.1B | +1.4% | 73.2% | $3.0B | $365.0M |
| Dec 2022filed Feb 24, 2023 | $59.3B | +21.7% | 70.6% | $18.3B | $14.5B |
| Dec 2021filed Feb 25, 2022 | $48.7B | +17.3% | 72.0% | $13.2B | $13.0B |
| Dec 2020filed Feb 25, 2021 | $41.5B | +6.1% | 67.2% | $5.5B | $7.1B |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched MRK. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
26,825,098 shares short
-1,446,652 shares (-5.1%) vs Sep 30, 2026
1.1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
28,271,750 shares short
-6,158,962 shares (-17.9%) vs Sep 15, 2026
1.1% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
34,430,712 shares short
+4,143,365 shares (+13.7%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
30,287,347 shares short
+5,780,827 shares (+23.6%) vs Aug 14, 2026
1.2% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
24,506,520 shares short
-3,774,855 shares (-13.3%) vs Jul 31, 2026
1% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
28,281,375 shares short
-1,077,653 shares (-3.7%) vs Jul 15, 2026
1.1% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind MRK’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
USD 0.85 per share
Ex-dividend date: Sep 15, 2026
Recorded pay date: Oct 7, 2026 (past date)
Cash dividend · Polygon event record
USD 0.85 per share
Ex-dividend date: Jun 15, 2026
Recorded pay date: Jul 8, 2026 (past date)
Cash dividend · Polygon event record
USD 0.85 per share
Ex-dividend date: Mar 16, 2026
Recorded pay date: Apr 7, 2026 (past date)
Cash dividend · Polygon event record
USD 0.85 per share
Ex-dividend date: Dec 15, 2025
Recorded pay date: Jan 8, 2026 (past date)
Cash dividend · Polygon event record
USD 0.81 per share
Ex-dividend date: Sep 15, 2025
Recorded pay date: Oct 7, 2025 (past date)
Cash dividend · Polygon event record
USD 0.81 per share
Ex-dividend date: Jun 16, 2025
Recorded pay date: Jul 8, 2025 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
131 for 125 · forward split
Effective Jun 3, 2021
Each 125 pre-split shares become 131 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Feb 17, 1999
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
3 for 1 · forward split
Effective May 26, 1992
Each 1 pre-split share becomes 3 post-split shares.
Source: EODHD
3 for 1 · forward split
Effective May 26, 1988
Each 1 pre-split share becomes 3 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective May 27, 1986
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 1, 1972
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if MRK is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
479 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Nov 6, 2026
Smart-money 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 86 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 6
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
3,866 filers reported a long position in MRK for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
46.3%
of the 2B shares 13-F filers reported
Moves vs Q1 2026
9 added1 trimmed
Net shares held
+0.4%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $29.2B · 227M shares | 227M | +0.5% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $20.7B · 161.3M shares | 161.3M | +0.2% |
| 3 | STATE STREET CORP | $15.6B · 120.4M shares | 120.4M | +0.9% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | $11.1B · 86.2M shares | 86.2M | +2.3% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | $8.7B · 67.7M shares | 67.7M | +0.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $7.8B · 60.7M shares | 60.7M | +2% |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7B · 54.4M shares | 54.4M | +9.2% |
| 8 | MORGAN STANLEY | $6.3B · 48.6M shares | 48.6M | +2.1% |
| 9 | FMR LLC | $5.8B · 45.4M shares | 45.4M | +2.1% |
| 10 | JPMORGAN CHASE & CO | $5.7B · 43.9M shares | 43.9M | -17.2% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of MRK file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Apr 30, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 7.53% |
| Mar 27, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for MRK
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.